Odyssean »

Denali Therapeutics shares owned by Odyssean

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.2M 125k 25.72

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Denali Therapeutics

BlackRock
Baillie Gifford & Co
Temasek Holdings
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
FMR
Ubs Global Asset Management Americas
Goldman Sachs Group
Baker Bros. Advisors
Geode Capital Management
Holocene Advisors
Alliancebernstein
Dimensional Fund Advisors
Pictet Asset Management Holding SA

View all funds holding Denali Therapeutics